Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,491,115
in 20 filings, $14.5M under 10b5-1 plans

Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ROBINS CHAD M −$14.9M CEO and Chairman sold 22% of stake
  2. RUBINSTEIN JULIE −$10.2M President and COO sold 50% of stake
  3. LO FRANCIS −$4.0M Chief People Officer sold 39% of stake
  4. NEUPERT PETER M −$3.1M Director sold 49% of stake
  5. HERSHBERG ROBERT −$748K Director sold 40% of stake
Date Insider Transaction Shares Price Value Owned after
2023-03-06 Conroy Kevin T Director Grant or award +14,775 22,968
2023-03-06 Conroy Kevin T Director Grant or award · Stock Option (right to buy) +23,329 23,329
2023-03-06 Trigg Leslie Director Grant or award +14,775 25,907
2023-03-06 Trigg Leslie Director Grant or award · Stock Option (right to buy) +23,329 23,329
2023-03-06 PISKEL KYLE Principal Accounting Officer Grant or award +43,735 91,093
2023-03-06 PISKEL KYLE Principal Accounting Officer Sale −3,300 $8.57 $28K 87,793
2023-03-06 PISKEL KYLE Principal Accounting Officer Sale −229 $8.58 $2K 87,564
2023-03-06 LO FRANCIS Chief People Officer Grant or award +85,697 175,285
2023-03-06 LO FRANCIS Chief People Officer Sale −6,816 $8.57 $58K 168,469
2023-03-06 LO FRANCIS Chief People Officer Grant or award · Stock Option (right to buy) +128,599 128,599
2023-03-06 Taylor Stacy L SVP and General Counsel Grant or award +85,697 158,556
2023-03-06 Taylor Stacy L SVP and General Counsel Sale −5,491 $8.57 $47K 153,065
2023-03-06 Taylor Stacy L SVP and General Counsel Grant or award · Stock Option (right to buy) +128,599 128,599
2023-03-06 ADAMS R MARK Chief Operating Officer Grant or award +88,652 202,170
2023-03-06 ADAMS R MARK Chief Operating Officer Sale −6,529 $8.57 $56K 195,641
2023-03-06 ADAMS R MARK Chief Operating Officer Grant or award · Stock Option (right to buy) +133,033 133,033
2023-03-06 PETERSON TYCHO Chief Financial Officer Grant or award +118,203 492,891
2023-03-06 PETERSON TYCHO Chief Financial Officer Grant or award · Stock Option (right to buy) +177,377 177,377
2023-03-06 BENZENO SHARON Chief Commercial Ofc Imm Med Grant or award +132,979 235,575
2023-03-06 BENZENO SHARON Chief Commercial Ofc Imm Med Sale −11,749 $8.57 $101K 223,826

Page 33 of 120 · 2,386 trades